Author/Authors :
Ahmadi, Samaneh Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Sanati, Hamidreza Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Hajikarimi, Majid Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Hoghooghi Esfahani, Alireza Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Beikmohammadi, Somayeh Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Khalilipur, Ehsan Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Bakhshandeh, Hooman Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Hajimolaali, Maryam Department of Education Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Farzaneh, Mehdi Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran , Noori, Mehdi Department of Interventional Cardiology - Rajaie cardiovascular - Medical and Research center - Iran University of Medical Sciences, Tehran, I.R.Iran
Abstract :
Background: We sought to assess the feasibility and outcome of primary percutaneous coronary
intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Methods: Between April 2014 and April 2015, consecutive STEMI patients who underwent
primary PCI were prospectively enrolled in a primary PCI registry. The patients’
demographics, risk factors, procedural characteristics, and in-hospital and 6-month major
adverse cardiac events (MACE) were assessed.
Results: A total of 393 patients underwent primary PCI during this period. The mean age was
58±11 years and 80.6% were male. Additionally, 40.7% of the patients were hypertensive,
37.9% had dyslipidemia, 37.7% were smokers, and 29% had diabetes mellitus. Single-vessel
disease was found in 36.6% of the study population, 2-vessel disease in 30.5%, and
multivessel disease in 27.7%. At admission, 74.5% of the patients had TIMI grade 0 flow.
Following revascularization, 74.7% achieved TIMI grade 3 flow, 22% TIMI grade 2 flow,
and 1.8% TIMI grade 1 flow—whereas 1.5% had TIMI grade 0 flow. The predictors of the
TIMI flow grade after primary PCI included history of diabetes mellitus, lesion severity,
time elapsed from symptom onset to admission, and use of thrombectomy. Stent thrombosis
developed in 5.6% of the patients; it was more frequent among those receiving bare-metal
stents. The in-hospital and 6-month mortality rates were 5.9% and 2.3%, correspondingly.
In-hospital mortality was strongly related to the TIMI flow grade.
Conclusions: Our study demonstrated that the outcome of primary PCI was strongly related to the
postprocedural TIMI flow grade. Patients with lower TIMI flow grades postprocedurally
should receive special attention.
Keywords :
ST-segment elevation myocardial infarction , Primary PCI , Thrombolysis in myocardial infarction (TIMI) flow , Major adverse cardiovascular events